Literature DB >> 660445

Bioequivalence and interchangeability.

S Hwang, P B Huber, M Hesney, K C Kwan.   

Abstract

Mesh：

Year:  1978        PMID： 660445     DOI： 10.1002/jps.2600670603

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN： 0022-3549            Impact factor:   3.534


× No keyword cloud information.
  4 in total

1.  Subject-by-formulation interaction in bioequivalence: conceptual and statistical issues. FDA Population/Individual Bioequivalence Working Group. Food and Drug Administration.

Authors:  W W Hauck; T Hyslop; M L Chen; R Patnaik; R L Williams
Journal:  Pharm Res       Date:  2000-04       Impact factor: 4.200

2.  Individual bioequivalence. New concepts in the statistical assessment of bioequivalence metrics. FDA Individual Bioequivalence Working Group.

Authors:  R N Patnaik; L J Lesko; M L Chen; R L Williams
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

3.  Measuring switchability and prescribability: when is average bioequivalence sufficient?

Authors:  W W Hauck; S Anderson
Journal:  J Pharmacokinet Biopharm       Date:  1994-12

4.  Group sequential extensions of a standard bioequivalence testing procedure.

Authors:  A L Gould
Journal:  J Pharmacokinet Biopharm       Date:  1995-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.